Work

Shortwave Life Sciences

We executed a full rebrand and creative direction for Shortwave Lifesciences PLC to unify its corporate identity and strengthen market positioning across global life sciences and cannabinoid-focused sectors.

The project encompassed brand strategy, visual identity, messaging architecture and digital creative assets — capturing Shortwave’s commitment to science-led innovation, clinical rigor and commercial scale.

Our approach crafted a clear, cohesive brand narrative that reflects Shortwave’s diversified business units and strategic focus on novel therapeutics, product development and international partnerships. The updated visual identity system and creative language were designed to elevate stakeholder trust, support investor relations and enhance visibility with regulators, clinicians and industry partners.

Alongside the brand launch, we delivered an integrated creative suite including website design, investor-facing materials and campaign assets to ensure coherent cross-channel representation. The refreshed brand strengthens Shortwave’s corporate presence, supports future growth initiatives and positions the company as a credible, forward-looking leader in life sciences innovation, research and development.

Shortwave portfolio 02 BB_1
Shortwave portfolio 02 BB_7
Shortwave portfolio 02 BB_4
Shortwave portfolio 02 BB_2
Shortwave portfolio 02 BB_8
Shortwave portfolio 02 BB_5
Shortwave portfolio 02 BB_6
Shortwawe portfolio 02 BB-04
Shortwave portfolio 02 BB_9

"PPX's strategic insight and creative direction helped us articulate our vision with clarity and impact, elevating our brand across stakeholders, investors and partners."

Rolf Gerritsen

Executive Chairman, Shortwave Lifesciences PLC